Provided by Tiger Fintech (Singapore) Pte. Ltd.

Takeda Pharmaceutical Co Ltd

14.98
+0.08000.54%
Post-market: 14.62-0.3600-2.40%17:37 EDT
Volume:1.11M
Turnover:16.66M
Market Cap:45.82B
PE:36.19
High:15.07
Open:15.00
Low:14.89
Close:14.90
Loading ...

Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan

MT Newswires Live
·
22 Nov 2024

Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer

seekingalpha
·
21 Nov 2024

Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)

TIPRANKS
·
19 Nov 2024

Why this major drugmaker no longer has an ‘IT department’

Fortune
·
14 Nov 2024

Top brokers name 3 ASX shares to buy next week

MotleyFool
·
10 Nov 2024

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Business Wire
·
07 Nov 2024

Trump victory is a win for Japan equities, a loss for China – analyst

seekingalpha
·
06 Nov 2024

New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD

CNW Group
·
04 Nov 2024

Leading brokers name 3 ASX shares to buy today

MotleyFool
·
04 Nov 2024

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Takeda Pharmaceutical Company (TAK) and Voyager Therapeutics (VYGR)

TIPRANKS
·
01 Nov 2024

Takeda Pharmaceutical Co Ltd reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
01 Nov 2024

HUTCHMED Earns $20 Million Milestone Payment After Takeda Reaches Over $200 Million in Fruquintinib Sales

MT Newswires Live
·
31 Oct 2024

Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Increase; Fiscal-Year Outlook Raised

MT Newswires Live
·
31 Oct 2024

Takeda Pharmaceutical Posts Quarterly Net Profit, Raises Guidance -- Update

Dow Jones
·
31 Oct 2024

Takeda Raises 2024 Outlook: Now Expects Revenue Of ¥4.48T (Prior ¥4.35T) Vs. ¥4.497T Est.; And Core EPS Of ¥456 (Prior ¥431); Sees Adjusted Free Cash Flow Of ¥400B-¥500B (Prior ¥350B - ¥450B)

Benzinga
·
31 Oct 2024

Takeda Pharmaceutical Q2 2024 GAAP EPS ¥134.00 Up From ¥111.00 YoY, Sales ¥.176T Beat ¥1.084T Estimate

Benzinga
·
31 Oct 2024

Takeda Expected to Post Second-Quarter Net Profit -- Earnings Preview

Dow Jones
·
30 Oct 2024

Takeda Pharmaceutical Co Ltd expected to post earnings of JPY87.45 a share - Earnings Preview

Reuters
·
29 Oct 2024

Takeda Pharmaceutical, Boston Medical Center Team Up for Decarbonization Project

MT Newswires Live
·
24 Oct 2024

Takeda and BMC team on decarbonization across health care ecosystem

TIPRANKS
·
24 Oct 2024